Explore selected publications, evidence types, key findings, and registered studies with direct links to each primary record. This curated library is not a complete archive of the thousands of studies across the wider scientific literature.
8 publications
Showing records relevant to NK Peptide.
Key finding
The review identifies natural-killer-cell receptors that recognize specific HLA-presented peptide sequences and explains how this selectivity can support pathogen surveillance.
Oxford open immunology 2025
Peptide-specific NK-receptor evidence review. Relevant to NK Peptide
Key finding
A high-throughput HLA-E screen identified 500 candidate peptides, including ligands that selectively activated NKG2C-positive natural killer cells.
Nature communications 2023
NK-activating peptide discovery evidence. Relevant to NK Peptide
Key finding
Distinct cytomegalovirus UL40 peptides controlled expansion and differentiation of adaptive NKG2C-positive natural killer-cell populations.
Nature immunology 2018
Human peptide-specific adaptive NK evidence. Relevant to NK Peptide
Key finding
This review shows that inhibitory and activating NK receptors can distinguish peptide motifs within MHC-I complexes, altering the balance of NK-cell activation and inhibition.
Frontiers in immunology 2014
Peptide-dependent NK-recognition review. Relevant to NK Peptide
Key finding
The review describes how HLA-bound peptides tune KIR and CD94:NKG2 receptor signalling, allowing natural killer cells to sense changes in cellular peptide repertoires.
Immunological reviews 2015
Peptide-tuned NK-signalling review. Relevant to NK Peptide
Key finding
The study reports that rPL women with the HLA-B T/T variant had a lower percentage of NKG2A-educated NK cells (47.8%) compared to controls (66.4%) (p = 0.025).
American journal of reproductive immunology (New York, N.Y. : 1989) 2025
Research relevant to NK Peptide. Relevant to NK Peptide
Key finding
The study reports that overall, this study establishes a modular, nongenetically engineered uCAR-like NK platform that couples targeted recognition with enhanced tissue access.
Signal transduction and targeted therapy 2025
Research relevant to NK Peptide. Relevant to NK Peptide
Key finding
The study reports that notably, this vaccine maintains efficacy against MHC class I-deficient tumours resistant to cytotoxic T cells through the coordinated action of NK cells and CD4+ T cells.
Nature 2022
Research relevant to NK Peptide. Relevant to NK Peptide
This library supports source-led professional evaluation. Product-specific clinical and regulatory guidance provides the framework for interpreting the records in context.
Browse all products